microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zheng, Liduan ^a   Qi, Teng ^a   Yang, Dehua ^a   Qi, Meng ^a   Li, Dan ^a   Xiang, Xuan ^a   Huang, Kai ^a   Tong, Qiangsong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GELATINASE B; MICRORNA 9; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR ETS 1;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; DRUG BINDING SITE; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; STOMACH CANCER;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84873107500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055719     Document Type: Article

References (50)

1. Terry MB, Gaudet MM, Gammon MD, (2002) The epidemiology of gastric cancer. Semin Radiat Oncol 12: 111-127.
2. Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W, (2001) Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 115: 828-834.
3. Iorio MV, Croce CM, (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159.
4. Zhang Z, Li Z, Gao C, Chen P, Chen J, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88: 1358-1366.
5. Xia L, Zhang D, Du R, Pan Y, Zhao L, et al. (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379.
6. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, et al. (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46: 2295-2303.
7. Li Y, Wang F, Lee JA, Gao FB, (2006) MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. Genes Dev 20: 2793-2805.
8. Leucht C, Stigloher C, Wizenmann A, Klafke R, Folchert A, et al. (2008) MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat Neurosci 11: 641-648.
9. Shibata M, Kurokawa D, Nakao H, Ohmura T, Aizawa S, (2008) MicroRNA-9 modulates cajal-retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium. J Neurosci 28: 10415-10421.
10. Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, et al. (2009) MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19: 375-383.
11. Wilting SM, Snijders PJF, Verlaat W, Jaspers A, van de Wiel MA, et al. (2012) Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene doi: 10.1038/onc.2012.20.
12. Omura N, Li CP, Li A, Hong SM, Walter K, et al. (2008) Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 7: 1146-1156.
13. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, et al. (2008) Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 7: 35.
14. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, et al. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737-2743.
15. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, et al. (2009) Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 28: 82.
16. Wan HY, Guo LM, Liu T, Liu M, Li X, et al. (2010) Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9: 16.
17. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, et al. (2011) Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 6: 1189-1197.
18. Saito Y, Suzuki H, Taya T, Nishizawa M, Tsugawa H, et al. (2012) Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs. Biochem Biophys Res Commun 426: 33-37.
19. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y, (2011) MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 129: 2611-2620.
20. Ke Y, Ning T, Wang B, (1994) Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1. Zhonghua Zhong Liu Za Zhi 16: 7-10.
21. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ, (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342.
22. Sahin A, Velten M, Pietsch T, Knuefermann P, Okuducu AF, et al. (2005) Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. Int J Mol Med 15: 771-776.
23. Endo K, Shirai A, Furukawa M, Yoshizaki T, (2006) Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Hum Pathol 37: 1111-1116.
24. Nakayama T, Ito M, Ohtsuru A, Naito S, Sekine I, (2001) Expression of the ets-1 proto-oncogene in human colorectal carcinoma. Mod Pathol 14: 415-422.
25. Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
26. Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R, (2012) Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 27: 1759-1764.
27. Hildebrandt MAT, Gu J, Lin J, Ye Y, Tan W, et al. (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29: 5724-5728.
28. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561.
29. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
30. Hsu PY, Deatherage DE, Rodriguez BAT, Liyanarachchi S, Weng YI, et al. (2009) Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 69: 5936-5945.
31. Guo LM, Pu Y, Han Z, Liu T, Li YX, et al. (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 276: 5537-5546.
32. Liu S, Kumar SM, Lu H, Liu A, Yang R, et al. (2012) MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol 226: 61-72.
33. Zhang H, Qi M, Li S, Qi T, Mei H, et al. (2012) microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells. Mol Cancer Ther 11: 1454-1466.
34. Jang BG, Kim WH, (2011) Molecular pathology of gastric carcinoma. Pathobiology 78: 302-310.
35. Wang XT, Xie YB, Xiao Q, (2012) siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells. World J Gastroenterol 18: 1903-1914.
36. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R, (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105: 1608-1613.
37. Kim DH, Saetrom P, Snøve O Jr, Rossi JJ, (2008) MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA 105: 16230-16235.
38. Younger ST, Corey DR, (2011) Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res 39: 5682-5691.
39. Kim JK, Diehl JA, (2009) Nuclear cyclin D1: An oncogenic driver in human cancer. J Cell Physiol 220: 292-296.
40. Chen RW, Bemis LT, Amato CM, Myint H, Tran H, et al. (2008) Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112: 822-829.
41. Yu Y, Zhang YC, Zhang WZ, Shen LS, Hertzog P, et al. (2003) Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol 9: 2154-2159.
42. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, et al. (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 71: 3552-3562.
43. Chan YC, Khanna S, Roy S, Sen CK, (2011) miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem 286: 2047-2056.
44. Jiang G, Zheng L, Pu J, Mei H, Zhao J, et al. (2012) Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells. PLoS ONE 2012 7: e31379.
45. Dai Y, Zhou X, (2010) Computational methods for the identification of microRNA targets. Open Access Bioinformatics 2: 29-39.
46. Dweep H, Sticht C, Pandey P, Gretz N, (2011) miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839-847.
47. Zheng L, Jiang G, Mei H, Pu J, Dong J, et al. (2010) Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells. BMC Cancer 10: 33.
48. Tong QS, Jiang GS, Zheng LD, Tang ST, Cai JB, et al. (2008) Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines. Anti-Cancer Drugs 19: 573-581.
49. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, et al. (2005) Cell migration and invasion assays. Methods 37: 208-215.
50. Zheng B, Liang L, Wang C, Huang S, Cao X, et al. (2011) MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-7583.